MedTrace Logo

Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid Leukemia

NCT01290107 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2016-05-18

No results posted yet for this study

Summary

RATIONALE: Studying samples of bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is looking at bone marrow samples from patients with acute myeloid leukemia.

Conditions

Interventions

GENETIC

DNA analysis

GENETIC

gene rearrangement analysis

GENETIC

microarray analysis

GENETIC

polymerase chain reaction

OTHER

immunological diagnostic method

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Eric Guest, MD · Children's Mercy Hospital Kansas City

Eligibility

Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2015-01-31
Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01290107 on ClinicalTrials.gov